Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A Drug-By-Drug Analysis Of Merck's Big Earnings Miss
Forbes
Wednesday, May 1, 2013 - 9:40am
tags:
Merck, earnings
Drugmakers Get Reprieve From Medicare Cost-Cutting Board
Bloomberg
Wednesday, May 1, 2013 - 9:36am
tags:
Medicare
Is All Well With These 4 Pharmaceutical Powerhouses?
Motley Fool
Wednesday, May 1, 2013 - 9:32am
tags:
Merck, Pfizer, GSK, Eli Lilly
Vertex posts loss, raises cystic fibrosis sales view
Reuters
Wednesday, May 1, 2013 - 9:09am
tags:
Vertex Pharmaceuticals, earnings
Raptor's FDA Approval Is New Test For Orphan Drug Pricing
TheStreet.com
Wednesday, May 1, 2013 - 9:09am
tags:
FDA, Raptor Pharmaceuticals, orphan drugs, procysbi, nephropathic cystinosis
Merck first-quarter sales disappoint
Yahoo/Reuters
Wednesday, May 1, 2013 - 9:06am
tags:
Merck, earnings
Novo Nordisk First-Quarter Profit Climbs on Insulins, Victoza
Bloomberg
Wednesday, May 1, 2013 - 9:04am
tags:
Novo Nordisk, earnings
Cytokinetics: A New Approach to Treating a Broken Heart
Motley Fool
Tuesday, April 30, 2013 - 10:54am
tags:
congestive heart failure, Cytokinetics, Omecamtiv Mecarbil, Amgen
Merck’s HPV Vaccine May Protect Girls With Fewer Doses
Bloomberg
Tuesday, April 30, 2013 - 10:32am
tags:
Merck, vaccines, HPV, Gardasil
Pfizer to seek re-examination of Xeljanz following negative opinion
Yahoo/Fly on the Wall
Tuesday, April 30, 2013 - 10:31am
tags:
Pfizer, Xeljanz
SEC Probes Former Dendreon CEO Stock Sales
Pharmalot
Tuesday, April 30, 2013 - 9:50am
tags:
SEC, Dendreon, Mitchell Gold
On verge of $13B merger, Valeant and Actavis stop talking
Fierce Pharma
Tuesday, April 30, 2013 - 9:47am
tags:
M&A, Valeant Pharmaceuticals, Actavis
Aveo Kidney Cancer Drug May Need More Study, FDA Says
Bloomberg
Tuesday, April 30, 2013 - 9:46am
tags:
kidney cancer, FDA, Aveo Pharmaceuticals, tivozanib
3 Biotech Companies Ripe for a Takeover
Motley Fool
Tuesday, April 30, 2013 - 9:00am
tags:
M&A, biotech, Regeneron, Bayer, Arena Pharmaceuticals, GSK, Theravance
OncoGenex initiates clincal trial of OGX-427
The Fly on the Wall
Tuesday, April 30, 2013 - 8:58am
tags:
OGX-427, OncoGenex, bladder cancer
FDA panel says Allergan's Juvederm data supports product effectiveness
Yahoo/Fly on the Wall
Tuesday, April 30, 2013 - 8:53am
tags:
FDA, Allergan, Juvederm, advisory panels, facial fillers
Merck Says Jury Rules in Its Favor in Fosamax Trial
Bloomberg
Tuesday, April 30, 2013 - 8:49am
tags:
Fosamax, Merck, osteoporosis
Zoetis profit beats Street on strong pet product sales
Reuters
Tuesday, April 30, 2013 - 8:41am
tags:
earnings, Zoetis, animal health
Pfizer Lowers 2013 Forecast After Sales Miss Analyst Estimates
Bloomberg
Tuesday, April 30, 2013 - 8:38am
tags:
earnings, Pfizer
United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy
Seeking Alpha
Tuesday, April 30, 2013 - 8:37am
tags:
United Therapeutics, PAH, pulmonary arterial hypertension, Remodulin, Pluristem Therapeutics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.